Johnson & Johnson
Price & Volume
Stats
See more52W Range | $145.39-$250.24 |
Market Cap | $570.5B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $96.3B |
Revenue Growth (YoY) | 9.9% |
Gross Profit (12 Mos) | $65.5B |
Diluted EPS | $8.63 |
News
See moreYahoo Finance • 2 hours ago
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
Yahoo Finance • 8 hours ago
IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
Yahoo Finance • 18 hours ago
Talc Verdict Tests Johnson & Johnson Balance Of Legal Risk And Growth
Yahoo Finance • 19 hours ago
Noteworthy Wednesday Option Activity: LLY, JNJ, CASY
About
CEO | Mr. Joaquin Duato |
Address | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 138,200 |